Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · IEX Real-Time Price · USD
1.830
-0.410 (-18.30%)
At close: Mar 28, 2024, 4:00 PM
1.870
+0.040 (2.19%)
After-hours: Mar 28, 2024, 7:59 PM EDT

Akebia Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Net Income
-51.93-94.23-282.02-384.84-279.66-143.59-73.67-135.75-60.72-123.93
Upgrade
Depreciation & Amortization
41.8535.2836.1332.6636.422.420.620.30.10.05
Upgrade
Share-Based Compensation
9.3217.8522.7424.4611.9319.048.875.834.716.01
Upgrade
Other Operating Activities
-22.62-32.06-29.8217.34-26.1224.638.03187.533.53.49
Upgrade
Operating Cash Flow
-23.38-73.15-252.97-110.39-257.44-97.49-56.1657.91-52.41-27.48
Upgrade
Capital Expenditures
0-0.11-0.06-0.32-6.66-1.61-1.62-2.66-0.41-0.23
Upgrade
Acquisitions
000006.150000
Upgrade
Change in Investments
0040-39.69217.8332.05-175.6415.37-13.27-65.12
Upgrade
Investing Cash Flow
0-0.1139.94-40211.1836.59-177.2612.71-13.69-65.35
Upgrade
Share Issuance / Repurchase
6.797.688.95211.7526.396.58116.2566.9783.1104.17
Upgrade
Debt Issued / Paid
-32-33019.9862.67-0.02-0.01-0.02-0.01-0
Upgrade
Other Financing Activities
-4044.78------0.24
Upgrade
Financing Cash Flow
-25.2114.6133.73231.7288.9796.56116.2466.9583.09104.4
Upgrade
Net Cash Flow
-48.59-58.67-79.2981.3342.7135.66-117.18137.561711.57
Upgrade
Free Cash Flow
-23.38-73.27-253.02-110.71-264.1-99.1-57.7855.24-52.82-27.71
Upgrade
Free Cash Flow Margin
-12.02%-25.05%-119.55%-37.57%-78.83%-47.70%-31.88%3598.96%--
Upgrade
Free Cash Flow Per Share
-0.13-0.40-1.52-0.80-2.23-1.71-1.331.47-2.00-1.80
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).